Management of Uncontrolled Diabetes Mellitus
Uncontrolled diabetes requires immediate insulin therapy for Type 1 diabetes and insulin initiation when oral agents fail to control glycemic levels in Type 2 diabetes, with treatment intensity guided by diabetes type, clinical context, and presence of acute complications. 1
Initial Assessment and Diagnosis Confirmation
Confirm the diagnosis and determine diabetes type:
- Measure fasting blood glucose ≥126 mg/dL (7.0 mmol/L) on two occasions or HbA1c ≥6.5% to confirm diabetes 1, 2
- Check HbA1c to distinguish pre-existing diabetes (HbA1c ≥6.5%) from stress hyperglycemia (HbA1c <6.5%) in acutely ill patients 3
- Assess for diabetic ketoacidosis in Type 1 diabetes by checking for ketones, as insulin deficiency results in DKA within hours 1, 4
- Rule out hyperosmolar hyperglycemic state in Type 2 diabetes when glucose >180 mg/dL (10 mmol/L) with polyuria/glycosuria 1
Type 1 Diabetes Management
Type 1 diabetes always requires insulin therapy using a basal-bolus regimen:
- Administer basal insulin with one or two injections of slow- or intermediate-acting insulin daily 1
- Never stop basal insulin, even with normoglycemia, due to major risk of ketoacidosis 1
- Add prandial insulin using ultra-rapid analogues (5-minute onset) before meals, with larger amounts after carbohydrate-rich meals 1
- Avoid rapid (regular) insulin due to delayed action (20 minutes vs. 5 minutes) and prolonged duration (6 hours vs. 3 hours needed post-prandially) 1
- Alternative: continuous subcutaneous insulin delivery via pump 1
- Reduce basal insulin dose if hypoglycemia occurs, but maintain continuous coverage 1
Type 2 Diabetes Management
For Type 2 diabetes, escalate therapy systematically based on glycemic control:
Initial Therapy
- Start with non-insulin therapies including oral glucose-lowering drugs 1
- Metformin is first-line if renal function is normal (eGFR >30 mL/min/1.73 m²) 2
- Consider GLP-1 receptor agonists, noting they reduce gastric emptying and may cause gastroparesis 1
When to Add Insulin
- Initiate insulin when non-insulin therapies no longer control glycemic levels 1
- For blood glucose ≥250 mg/dL with symptoms, start insulin immediately at 0.2-0.3 U/kg/day as basal insulin plus correction doses 2
- Insulin and oral agents can be combined 1
Acute Hyperglycemic Crisis Management
For critically ill patients or those with hyperglycemic emergencies:
- Initiate continuous IV insulin infusion when blood glucose >180 mg/dL, targeting glucose ≤180 mg/dL 1, 3
- In ICU settings, maintain glucose 140-180 mg/dL (7.8-10 mmol/L) for most patients 1
- More stringent targets of 110-140 mg/dL may be appropriate for cardiac surgery patients, if achievable without hypoglycemia 1
- Administer IV insulin, rehydrate with NaCl solutions, and provide IV potassium (usually after initial hours of insulin/NaCl treatment) 5
- Administer NaHCO3 only if blood pH <7.1 5
Glycemic Targets and Monitoring
Set appropriate glucose targets based on clinical context:
- General inpatient target: 140-180 mg/dL (7.8-10 mmol/L) 1
- Outpatient target: systolic BP <130 mmHg, with HbA1c goals individualized 1
- In advanced CKD (eGFR <30), target HbA1c 7-8% to balance control with hypoglycemia risk 2
- Monitor blood glucose at every routine visit 1
Hypoglycemia Prevention and Management
Preventing and treating hypoglycemia is critical, especially in elderly and critically ill patients:
- Administer 15-20 g glucose orally for conscious patients with hypoglycemia 1
- Retest after 15 minutes; repeat treatment if hypoglycemia persists 1
- Prescribe glucagon for all patients at significant risk of severe hypoglycemia 1
- Raise glycemic targets for several weeks in patients with hypoglycemia unawareness to reverse the condition 1
- Elderly patients have increased hypoglycemia risk due to renal failure, malnutrition, and impaired counterregulatory responses 1
Lifestyle and Adjunctive Measures
Implement comprehensive lifestyle modifications:
- Prescribe at least 150 minutes/week of moderate-intensity aerobic exercise (50-70% maximum heart rate), spread over at least 3 days with no more than 2 consecutive days without exercise 1
- Add resistance training at least twice weekly 1
- Consider bariatric surgery for BMI >35 kg/m² with difficult-to-control diabetes 1
- Provide annual influenza vaccine and pneumococcal vaccine for patients ≥2 years 1
Common Pitfalls to Avoid
- Never discontinue basal insulin in Type 1 diabetes, even with normal glucose, as this leads to rapid ketoacidosis 1
- Avoid overly aggressive glucose lowering in elderly or critically ill patients, as hypoglycemia increases mortality 1
- Do not rely solely on continuous glucose monitor readings for diagnosis; confirm with venous plasma glucose 6
- Recognize that stress hyperglycemia is an independent prognostic factor for morbidity and mortality, requiring treatment even in non-diabetics 1, 3
- In patients with renal insufficiency, decreased gluconeogenesis and impaired insulin clearance increase hypoglycemia risk 1, 2